Alzheimer’s disease (AD) is a leading cause of dementia in older adults, and effective and widely applicable treatment options remain limited. Photobiomodulation (PBM) has shown promise for AD. However, reported estimates of the delivered dose after transcranial propagation vary widely, limiting translation from animal models to clinical settings.
Objective:
Building on our team’s prior clinical findings, this study evaluated whether an 810 nm/10 Hz pulsed PBM regimen improves cognitive performance and reduces Aβ42 burden in APP/PS1 mice.
Methods:
APP/PS1 mice received PBM using an 810 nm LED pulsed at 10 Hz. Irradiation was delivered for 540 sec/day, 6 days/week, for 7 weeks, with a scalp-surface power density of 0.025 W/cm2 and an energy density of 13.5 J/cm2. Cognitive function was evaluated using the Morris water maze, and Aβ42 burden was quantified by immunofluorescence.
Results:
Cortical and hippocampal Aβ42 plaque burden was reduced, p < 0.01. Exploratory correlation analyses suggested an association between hippocampal Aβ42 plaque number and reversal-learning performance in the histological subset, p = 0.02. The microglia-Aβ42 colocalization ratio increased by 7.53%, p = 0.03, indicating enhanced spatial association between microglia and Aβ42 after PBM.
Conclusions:
These findings support further evaluation of this 810 nm/10 Hz pulsed PBM regimen in AD mouse models and highlight the value of standardized PBM parameter reporting in preclinical studies.
MoJJ, LiJY, YangZ, et al.Efficacy and safety of anti-amyloid-beta immunotherapy for Alzheimer’s disease: A systematic review and network meta-analysis. Ann Clin Transl Neurol2017;4(12):931–942; doi: 10.1002/acn3.469
Tahami MonfaredAA, ByrnesMJ, WhiteLA, et al.The humanistic and economic burden of Alzheimer’s disease. Neurol Ther2022;11(2):525–551; doi: 10.1007/s40120-022-00335-x
4.
AbeysingheA, DeshapriyaR, UdawatteC. Alzheimer’s disease; a review of the pathophysiological basis and therapeutic interventions. Life Sci2020;256:117996; doi: 10.1016/j.lfs.2020.117996
5.
ShenQ, GuoH, YanY. Photobiomodulation for neurodegenerative diseases: A scoping review. Int J Mol Sci2024;25(3):1625; doi: 10.3390/ijms25031625
6.
AmaroliA, Clemente VargasMR, PasqualeC, et al.Photobiomodulation on isolated mitochondria at 810 nm: First results on the efficiency of the energy conversion process. Sci Rep2024;14(1):11060; doi: 10.1038/s41598-024-61740-w
7.
RaveraS, ColomboE, PasqualeC, et al.Mitochondrial bioenergetic, photobiomodulation and trigeminal branches nerve damage, what’s the connection? A review. Int J Mol Sci2021;22(9):4347; doi: 10.3390/ijms22094347
8.
Santana-BlankL, Rodríguez-SantanaE. The interaction of light with nanoscopic layers of water may be essential to the future of photobiomodulation. Photomed Laser Surg2010;28 Suppl 1(S1):S173–S174; doi: 10.1089/pho.2009.2745
RamanishankarA, SAS, BegumRF, et al.Unleashing light’s healing power: An overview of photobiomodulation for Alzheimer’s treatment. Future Sci OA2024;10(1):FSO922; doi: 10.2144/fsoa-2023-0155
11.
LiQ, PengJ, LuoY, et al.Far infrared light irradiation enhances Abeta clearance via increased exocytotic microglial ATP and ameliorates cognitive deficit in Alzheimer’s disease-like mice. J Neuroinflammation2022;19(1):145; doi: 10.1186/s12974-022-02521-y
12.
IaccarinoHF, SingerAC, MartorellAJ, et al.Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature2016;540(7632):230–235; doi: 10.1038/nature20587
13.
ChenH, LiN, LiuN, et al.Photobiomodulation modulates mitochondrial energy metabolism and ameliorates neurological damage in an APP/PS1 mouse model of Alzheimer’s disease. Alzheimers Res Ther2025;17(1):72; doi: 10.1186/s13195-025-01714-w
14.
TaoL, LiuQ, ZhangF, et al.Microglia modulation with 1070-nm light attenuates Abeta burden and cognitive impairment in Alzheimer’s disease mouse model. Light Sci Appl2021;10(1):179; doi: 10.1038/s41377-021-00617-3
15.
StepanovYV, GolovynskaI, ZhangR, et al.Near-infrared light reduces β-amyloid-stimulated microglial toxicity and enhances survival of neurons: Mechanisms of light therapy for Alzheimer’s disease. Alzheimers Res Ther2022;14(1):84; doi: 10.1186/s13195-022-01022-7
16.
TakatoriS, KondoM, TomitaT. Unraveling the complex role of microglia in Alzheimer’s disease: Amyloid beta metabolism and plaque formation. Inflamm Regen2025;45(1):16; doi: 10.1186/s41232-025-00383-4
17.
HendersonTA. Can infrared light really be doing what we claim it is doing? Infrared light penetration principles, practices, and limitations. Front Neurol2024;15:1398894; doi: 10.3389/fneur.2024.1398894
18.
GuoR, LiD, LiF, et al.Effects of whole-head 810 nm near-infrared therapy on cognitive and neuropsychiatric symptoms in Alzheimer’s disease: A pilot study. J Alzheimers Dis2025;104(1):52–60; doi: 10.1177/13872877251313819
19.
Garcia-AllozaM, RobbinsEM, Zhang-NunesSX, et al.Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis2006;24(3):516–524; doi: 10.1016/j.nbd.2006.08.017
20.
KellyP, DenverP, SatchellSC, et al.Microvascular ultrastructural changes precede cognitive impairment in the murine APPswe/PS1dE9 model of Alzheimer’s disease. Angiogenesis2017;20(4):567–580; doi: 10.1007/s10456-017-9568-3
21.
ReisererRS, HarrisonFE, SyverudDC, et al.Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer’s disease. Genes Brain Behav2007;6(1):54–65; doi: 10.1111/j.1601-183X.2006.00221.x
22.
FestingMF, AltmanDG. Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J2002;43(4):244–258; doi: 10.1093/ilar.43.4.244
23.
The Jackson Laboratory. 034832 - APP/PS1 strain details. Available from: https://www.jax.org/strain/005864 [Last accessed: March15, 2026].
24.
MagaAM. Postnatal development of the craniofacial skeleton in Male C57BL/6J mice. J Am Assoc Lab Anim Sci2016;55(2):131–136.
25.
CronshawM, ParkerS, GrootveldM, et al.Photothermal effects of high-energy photobiomodulation therapies: An in vitro investigation. Biomedicines2023;11(6):1634; doi: 10.3390/biomedicines11061634
26.
ParvinP, DehghanpourHR, BahrambeigiA, et al.Tissue thermal response in photobiomodulation therapy: A theoretical study. SciBase Dent Oral Sci2023;1(1):1001; doi: 10.52768/dentistry/1001
27.
GuillenAR, TruongDQ, FariaPC, et al.High-resolution computational modeling of transcranial photobiomodulation: Light propagation and thermal effects. Neuromodulation2026;29(2):267–280; doi: 10.1016/j.neurom.2025.06.003
28.
ChangYC, LinBY, HsiehYP, et al.Noninvasive prediction of photon fluence rate in targeted brain regions for personalized transcranial photobiomodulation dosage: Model development and in silico evaluation. Biomed Opt Express2025;16(12):4929–4943; doi: 10.1364/BOE.570066
29.
SalehpourF, CassanoP, RouhiN, et al.Penetration profiles of visible and near-infrared lasers and light-emitting diode light through the head tissues in animal and human species: A review of literature. Photobiomodul Photomed Laser Surg2019;37(10):581–595; doi: 10.1089/photob.2019.4676
30.
TittelmeierJ, KaubL, MilzS, et al.Insufficient low-level near infrared light penetration challenges the efficacy of transcranial photobiomodulation. Brain Stimul2025;18(4):1220–1223; doi: 10.1016/j.brs.2025.07.001
31.
HendersonTA, MorriesLD. Near-infrared photonic energy penetration: Can infrared phototherapy effectively reach the human brain? Neuropsychiatr Dis Treat2015;11:2191–2208; doi: 10.2147/NDT.S78182
32.
TedfordCE, DeLappS, JacquesS, et al.Quantitative analysis of transcranial and intraparenchymal light penetration in human cadaver brain tissue. Lasers Surg Med2015;47(4):312–322; doi: 10.1002/lsm.22343
33.
SharmaSK, KharkwalGB, SajoM, et al.Dose response effects of 810 nm laser light on mouse primary cortical neurons. Lasers Surg Med2011;43(8):851–859; doi: 10.1002/lsm.21100
34.
Wong-RileyMT, LiangHL, EellsJT, et al.Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: Role of cytochrome c oxidase. J Biol Chem2005;280(6):4761–4771; doi: 10.1074/jbc.M409650200
35.
VorheesCV, WilliamsMT. Morris water maze: Procedures for assessing spatial and related forms of learning and memory. Nat Protoc2006;1(2):848–858; doi: 10.1038/nprot.2006.116
36.
ZhanmuO, YangX, GongH, et al.Paraffin-embedding for large volume bio-tissue. Sci Rep2020;10(1):12639; doi: 10.1038/s41598-020-68876-5
37.
StackEC, WangC, RomanKA, et al.Multiplexed immunohistochemistry, imaging, and quantitation: A review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis. Methods2014;70(1):46–58; doi: 10.1016/j.ymeth.2014.08.016
38.
FagetL, HnaskoTS. Tyramide signal amplification for immunofluorescent enhancement. Methods Mol Biol2015;1318:161–172; doi: 10.1007/978-1-4939-2742-5_16
39.
MorrisR. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods1984;11(1):47–60; doi: 10.1016/0165-0270(84)90007-4
40.
ArendashGW, KingDL, GordonMN, et al.Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res2001;891(1–2):42–53; doi: 10.1016/s0006-8993(00)03186-3
41.
MorelliniF, SivukhinaE, StoenicaL, et al.Improved reversal learning and working memory and enhanced reactivity to novelty in mice with enhanced GABAergic innervation in the dentate gyrus. Cereb Cortex2010;20(11):2712–2727; doi: 10.1093/cercor/bhq017
42.
AnackerC, HenR. Adult hippocampal neurogenesis and cognitive flexibility - linking memory and mood. Nat Rev Neurosci2017;18(6):335–346; doi: 10.1038/nrn.2017.45
43.
YangL, WuC, ParkerE, et al.Non-invasive photobiomodulation treatment in an Alzheimer disease-like transgenic rat model. Theranostics2022;12(5):2205–2231; doi: 10.7150/thno.70756
44.
MaC, YeY, ShiX, et al.Photobiomodulation mitigates blood-brain barrier disruption in APP/PS1 mouse model of Alzheimer’s disease by activating the AMPK pathway. Alzheimers Res Ther2025;17(1):141; doi: 10.1186/s13195-025-01787-7
45.
HuangYY, ChenAC, CarrollJD, et al.Biphasic dose response in low level light therapy. Dose Response2009;7(4):358–383; doi: 10.2203/dose-response.09-027.Hamblin
46.
SipionM, FerreiraFM, SchollerJ, et al.A randomized, blinded study of photobiomodulation in a mouse model of Alzheimer’s disease showed no preventive effect. Sci Rep2023;13(1):19828; doi: 10.1038/s41598-023-47039-2
47.
Van LankveldH, MaiAQ, LimL, et al.Simulation-based dosimetry of transcranial and intranasal photobiomodulation of the human brain: The roles of wavelength, power density, and skin tone. Biomed Opt Express2025;16(8):3295–3314; doi: 10.1364/BOE.567345
48.
JacquesSL. Optical properties of biological tissues: A review. Phys Med Biol2013;58(11):R37–R61; doi: 10.1088/0031-9155/58/11/R37
49.
GadaniSP, CalabresiPA. The calvaria stands alone: Unique aspects of the skull bone marrow-meninges border. Cell2023;186(17):3524–3526; doi: 10.1016/j.cell.2023.07.025
50.
LiY, DuY, YeF, et al.Photostimulation of skull bone marrow modulates neuroimmunity in sepsis-associated encephalopathy via the skull bone marrow-dura mater-brain axis. J Neuroinflammation2025;22(1):278; doi: 10.1186/s12974-025-03617-x
51.
SunZ, ZhangX, SoKF, et al.Targeting microglia in Alzheimer’s disease: Pathogenesis and potential therapeutic strategies. Biomolecules2024;14(7):833; doi: 10.3390/biom14070833
52.
HamblinMR. Mechanisms and mitochondrial redox signaling in photobiomodulation. Photochem Photobiol2018;94(2):199–212; doi: 10.1111/php.12864
53.
RaveraS, FarsettiE, MauraG, et al.810-nm photobiomodulation evokes glutamate release in normal and rotenone-dysfunctional cortical nerve terminals by modulating mitochondrial energy metabolism. Cells2025;14(2):67; doi: 10.3390/cells14020067
54.
ParkM, HoangGM, NguyenT, et al.Effects of transcranial ultrasound stimulation pulsed at 40 Hz on Abeta plaques and brain rhythms in 5xFAD mice. Transl Neurodegener2021;10(1):48; doi: 10.1186/s40035-021-00274-x
55.
HuangZ, HamblinMR, ZhangQ. Photobiomodulation in experimental models of Alzheimer’s disease: State-of-the-art and translational perspectives. Alzheimers Res Ther2024;16(1):114; doi: 10.1186/s13195-024-01484-x
56.
ChangSY, LeeMY. Photobiomodulation of neurogenesis through the enhancement of stem cell and neural progenitor differentiation in the central and peripheral nervous systems. Int J Mol Sci2023;24(20):15427; doi: 10.3390/ijms242015427
57.
CondelloC, YuanP, SchainA, et al.Microglia constitute a barrier that prevents neurotoxic protofibrillar Abeta42 hotspots around plaques. Nat Commun2015;6:6176; doi: 10.1038/ncomms7176
58.
NayakD, RothTL, McGavernDB. Microglia development and function. Annu Rev Immunol2014;32:367–402; doi: 10.1146/annurev-immunol-032713-120240
59.
Van OlstL, SimontonB, EdwardsAJ, et al.Microglial mechanisms drive amyloid-beta clearance in immunized patients with Alzheimer’s disease. Nat Med2025;31(5):1604–1616; doi: 10.1038/s41591-025-03574-1
60.
GreenTRF, RoweRK. Quantifying microglial morphology: An insight into function. Clin Exp Immunol2024;216(3):221–229; doi: 10.1093/cei/uxae023
61.
Lepiarz-RabaI, GbadamosiI, FloreaR, et al.Metabolic regulation of microglial phagocytosis: Implications for Alzheimer’s disease therapeutics. Transl Neurodegener2023;12(1):48; doi: 10.1186/s40035-023-00382-w
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
